Saturna Capital Corp Edwards Lifesciences Corp Transaction History

Saturna Capital Corp

$7.45 Billion
Q2 2024

A detailed history of Saturna Capital Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Saturna Capital Corp holds 22,916 shares of EW stock, worth $1.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

22,916

Previous 22,611 1.35%

Holding current value

$1.5 Million

Previous $2.16 Million 2.04%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$84.3 - $94.31 $25,711 - $28,764	305 Added 1.35%	22,916 $2.12 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $80,446 - $105,976	1,109 Added 5.16%	22,611 $2.16 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $7,405 - $9,331	-120 Reduced 0.55%	21,502 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $27,365 - $36,885	-395 Reduced 1.79%	21,622 $1.5 Million
Q2 2023 Aug 04, 2023	BUY	$81.41 - $94.33 $185,614 - $215,072	2,280 Added 11.55%	22,017 $2.08 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $84,062 - $95,665	1,132 Added 6.08%	19,737 $1.63 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $104,499 - $133,783	-1,530 Reduced 7.6%	18,605 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $4,118 - $5,364	50 Added 0.25%	20,135 $1.66 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $30,275 - $44,894	350 Added 1.77%	20,085 $1.91 Million
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $385,408 - $485,125	-3,780 Reduced 16.07%	19,735 $2.32 Million
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $31,911 - $39,204	300 Added 1.29%	23,515 $3.05 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $28,814 - $34,370	-280 Reduced 1.19%	23,215 $2.63 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $33,536 - $41,904	400 Added 1.73%	23,495 $2.43 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $33,045 - $38,081	420 Added 1.85%	23,095 $1.93 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $35,845 - $45,615	500 Added 2.25%	22,675 $2.07 Million
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $13,438 - $17,488	200 Added 0.91%	22,175 $1.77 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $842,961 - $1.13 Million	14,650 Added 200.0%	21,975 $1.52 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $13,102 - $20,250	250 Added 3.53%	7,325 $1.57 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $3,077 - $3,771	50 Added 0.71%	7,075 $1.56 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $6,855 - $8,704	-150 Reduced 2.09%	7,025 $1.22 Million
Q1 2018 May 10, 2018	SELL	$37.19 - $47.45 $92,975 - $118,625	-2,500 Reduced 25.84%	7,175 $1 Million
Q4 2017 Feb 06, 2018	BUY	$33.79 - $39.39 $6,758 - $7,878	200 Added 2.11%	9,675 $1.09 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $9,979 - $10,678	275 Added 2.99%	9,475 $996,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,200	9,200 $1.09 Million

Others Institutions Holding EW

# of Institutions

1,418

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Edwards Lifesciences Corp Transaction History